Evidence map›Paper›PMID 33450882›Full record

ArticleBrain sciences2021

Expanding the Clinical and Mutational Spectrum of the

Francesco Nicita, Chiara Aiello, Gessica Vasco, Massimiliano Valeriani, Fabrizia Stregapede, Andrea Sancesario, Michela Armando, Enrico Bertini

Open access · goldAbstract read
In one paragraph

Article in Brain sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Microdeletion in distal PLP1 enhancers causes hereditary spastic paraplegia 2.Annals of clinical and translational neurology · 2023
    Article
  6. PLP1 gene mutations cause spastic paraplegia type 2 in three families.Annals of clinical and translational neurology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Francesco NicitaUnit of Neuromuscular and Neurodegenerative Diseases, Department of Neuroscience, IRCCS Bambino Gesù Children's Hospital, 00146 Rome, Italy.ORCID 0000-0002-5612-821X
Chiara AielloUnit of Neuromuscular and Neurodegenerative Diseases, Department of Neuroscience, IRCCS Bambino Gesù Children's Hospital, 00146 Rome, Italy.
Gessica VascoUnit of Neurorehabilitation, Department of Neurorehabilitation, IRCCS Bambino Gesù Children's Hospital, 00050 Rome, Italy.
Massimiliano ValerianiUnit of Neurology, Department of Neuroscience, IRCCS Bambino Gesù Children's Hospital, 00165 Rome, Italy.ORCID 0000-0001-6602-103X
Fabrizia StregapedeUnit of Neuromuscular and Neurodegenerative Diseases, Department of Neuroscience, IRCCS Bambino Gesù Children's Hospital, 00146 Rome, Italy.
Andrea SancesarioUnit of Neurorehabilitation, Department of Neurorehabilitation, IRCCS Bambino Gesù Children's Hospital, 00050 Rome, Italy.ORCID 0000-0003-3350-2392
Michela ArmandoUnit of Neurorehabilitation, Department of Neurorehabilitation, IRCCS Bambino Gesù Children's Hospital, 00050 Rome, Italy.
Enrico BertiniUnit of Neuromuscular and Neurodegenerative Diseases, Department of Neuroscience, IRCCS Bambino Gesù Children's Hospital, 00146 Rome, Italy.
Bambino Gesù Children's Hospital · ITRoma Tre University · ITUniversity of Rome Tor Vergata · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The

Indexed as

DM20exon 3BHEMShypomyelinatingintron 3leukodystrophyPelizaeus-Merzbacher diseasePLP1proteolipid protein 1

Identifiers

PMID33450882
PMCPMC7828325
OpenAlexW3118437259

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.